Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Tinengotinib |
Trade Name | |
Synonyms | TT00420|TT 00420|TT-00420 |
Drug Descriptions |
Tinengotinib (TT-00420) is a multikinase inhibitor that targets AURKA, AURKB, FGFR1-3, VEGFR, JAK1/2, and CSF1R, potentially resulting in decreased cell proliferation and inhibition of tumor growth (PMID: 36223547). |
DrugClasses | Aurka Inhibitors 27 Aurkb Inhibitors 21 CSF1R Inhibitor 28 FGFR1 Inhibitor 28 FGFR2 Inhibitor 23 FGFR3 Inhibitor 19 JAK Inhibitor (Pan) 9 VEGFR Inhibitor (Pan) 36 |
CAS Registry Number | 2230490-29-4 |
NCIT ID | C162532 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Abiraterone + Enzalutamide + Tinengotinib | Abiraterone Enzalutamide Tinengotinib | 0 | 1 |
Abiraterone + Prednisone + Tinengotinib | Abiraterone Prednisone Tinengotinib | 0 | 1 |
Enzalutamide + Tinengotinib | Enzalutamide Tinengotinib | 0 | 0 |
Nab-paclitaxel + Tinengotinib | Nab-paclitaxel Tinengotinib | 0 | 1 |
Tinengotinib | Tinengotinib | 4 | 4 |